Reply to the Letter of Sun et al. [1] relating to Clin Chem Lab Med 2022;60(9):1365–72

References

1. Sun, X, Wang, Q, Shi, Q. Letter to the Editor relating to. Clin Chem Lab Med 2022;60:e243.10.1515/cclm-2022-0777Search in Google Scholar PubMed

2. Smith, TP, Kelly, S, Fahie-Wilson, MN. Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia. Clin Chem Lab Med 2022;60:1365–72. https://doi.org/10.1515/cclm-2022-0459.Search in Google Scholar PubMed

3. Hu, Y, Ni, J, Zhang, B, Cheng, W, Zhang, H, Ye, H, et al.. Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin. BMC Endocr Disord 2021;21:197. https://doi.org/10.1186/s12902-021-00861-z.Search in Google Scholar PubMed PubMed Central

4. Fahie-Wilson, MN, Smith, TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metabol 2013;27:25–42. https://doi.org/10.1016/j.beem.2013.07.002.Search in Google Scholar PubMed

5. Fahie-Wilson, MN, Bieglmayer, C, Kratzsch, J, Nusbaumer, C, Roth, HJ, Zaninotto, M, et al.. Roche Elecsys prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol. Clin Lab 2007;53:485–92.Search in Google Scholar

6. Sostaric, M, Bokulic, A, Marijancevic, D, Zec, I. Optimizing laboratory defined macroprolactin algorithm. Biochem Med 2019;29:G1–5. https://doi.org/10.11613/bm.2019.020706.Search in Google Scholar PubMed PubMed Central

7. Hauache, OM, Roche, AJ, Maia, ACM, Macile, RMB, Vieira, JGH. Screening for macroprolactinaemia and pituitary imaging studies. Clin Endocrinol 2002;57:327–32. https://doi.org/10.1046/j.1365-2265.2002.01586.x.Search in Google Scholar PubMed